Guo, Fengbiao http://orcid.org/0000-0003-1953-5083
Pan, Quanren
Chen, Ting
Liao, Shuzhen
Li, Shangmei
Li, Aifen
Chen, Shuxian
Chen, Jiaxuan
Xiao, Zengzhi
Su, Hongyong
Yang, Lawei
Yang, Chen
Liu, Hua-feng
Pan, Qingjun
Funding for this research was provided by:
National Natural Science Foundation of China (82070757, 82270770)
Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Noncommunicable Diseases (2022B1212030003)
The Stem Cell Preclinical Research Projects of the Affiliated Hospital of Guangdong Medical University
Affiliated Hospital of Guangdong Medical University “Clinical Medicine +” CnTech Co-operation Project (CLP2021B007)
Zhanjiang Science and Technology Project (2021A05060)
Article History
Received: 4 January 2023
Accepted: 26 July 2023
First Online: 21 August 2023
Declarations
:
: Ethics approval for the experiments was obtained from the laboratory animal ethical committee (LAEC) of Guangdong Medical University (license no. GDY2103031). The Ethics approval document entitled “Mechanism study of human umbilical cord mesenchymal stem cells alleviating the progression of lupus nephritis” was approved on August 25, 2021. All experiments were performed following relevant laws and institutional guidelines of the laboratory animal ethical committee (LAEC) of Guangdong Medical University. This study did not involve human subjects.
: Not applicable.
: The authors declare that they have no competing interests.